BerandaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Tutup sebelumnya
$0,57
Rentang hari
$0,58 - $0,60
Rentang tahun
$0,36 - $2,47
Kapitalisasi pasar
3,51 jt USD
Volume Rata-Rata
33,48 rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Blockchain Media Indonesia
5 jam yang lalu
Nasdaq Siap Ledakkan 4 Altcoin Ini Lewat ETF di Akhir Tahun
0,39%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 2,70 jt | 17,90% |
Laba bersih | 7,67 jt | 338,64% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -2,70 jt | -18,43% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,47 jt | 364,45% |
Total aset | 9,87 jt | 84,28% |
Total liabilitas | 3,70 jt | -28,71% |
Total ekuitas | 6,17 jt | — |
Saham yang beredar | 5,82 jt | — |
Harga terhadap nilai buku | 0,54 | — |
Tingkat pengembalian aset | -101,58% | — |
Tingkat pengembalian modal | -152,86% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 7,67 jt | 338,64% |
Kas dari operasi | 9,74 jt | 1.476,41% |
Kas dari investasi | — | — |
Kas dari pembiayaan | -1,71 jt | -186,10% |
Perubahan kas bersih | 8,04 jt | 714,92% |
Arus kas bebas | 28,88 rb | -97,37% |
Tentang
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Didirikan
2000
Kantor pusat
Situs
Karyawan
14
